In the setting of severe acute asthma, electrocardiographic abnormalities are not uncommon and some patients will develop reversible systolic dysfunction. However, acute myocardial infarction and potentially fatal arrhythmias are rare. We report the case of a middle-aged indigenous male who suffered an ST-elevation myocardial infarction and then pulseless ventricular tachycardia arrest while still in the acute phase of treatment for status asthmaticus.
CASE HISTORY
A 57-year-old Torres Strait Islander male with known asthma presented to the emergency department with severe respiratory distress due to asthma exacerbation for which he had seen his GP earlier that day. His most recent emergency department presentation for treatment of severe acute asthma was two years prior; he had never required admission to the intensive care unit for his asthma. Spirometry results from the thoracic medicine outpatient clinic the previous year showed an FEV1 of 1.58 l (56%) and FVC 2.95 l (78%). He was an ex-smoker and used intermittent salbutamol and inhaled corticosteroid therapy. On arrival in the emergency department he was commenced on continuous nebulised salbutamol therapy. Within minutes his level of consciousness rapidly deteriorated and he then collapsed, with a loss of cardiac output requiring two minutes of cardiopulmonary resuscitation, endotracheal intubation and mechanical ventilation. Arterial blood gases at this time showed severe respiratory acidosis (pH 6.86, Pco 2 179, Po 2 318, HCO 3 31.5, BE -7.8). Cardiac output returned and he was commenced on a salbutamol infusion. While still in the emergency department and awaiting transfer to the intensive care unit, the patient became profoundly diaphoretic and developed acute ischaemic changes on the electrocardiograph monitor. A 12-lead electrocardiogram (ECG) showed ST-segment elevation in leads V2-V5, meeting criteria for thrombolytic therapy (Figure 1 ).
Prior to thrombolysis and given the patient's acute loss of consciousness, the decision was made to perform a computed tomography brain scan to exclude an intracranial bleed. En route to radiology the patient had an episode of nonsustained ventricular tachycardia (VT) lasting less than 10 seconds and resolving spontaneously. The computed tomography brain scan was normal and immediately after completion of the scan the patient was given intravenous tenectaplase 40 mg. He then developed pulseless VT. Immediate cardiopulmonary resuscitation was instituted, with three asynchronous direct current shocks, two adrenaline boluses and intravenous amiodarone 300 mg. After 10 minutes of pulseless electrical activity, bilateral anterior needle thoracostomies were performed and cardiopulmonary resuscitation was continued for approximately 17 minutes before return of spontaneous circulation.
The patient was transferred to the intensive care unit where within 10 minutes he suffered another brief episode of VT, which reverted with single shock direct current cardioversion, followed by atrial fibrillation at a rate of 100 to 110 beats per minute. During the patient's first 24 hours in intensive care he was given enoxaparin, aspirin and infusions of amiodarone, adrenaline and noradrenaline, as well as nebulised salbutamol and ipratropium. Cardiac enzyme levels peaked on day two to three, with a troponin-I rise to 11 µg/l and a creatine kinase of 841 U/l. The patient's ST segments normalised, cardiac rhythm reverted to sinus and ventilation parameters gradually improved. A transthoracic echocardiogram on day three showed normal systolic function and the patient was successfully extubated on day four with no evident neurological deficit. A follow-up echocardiogram a week later was normal apart from evidence of mild pulmonary hypertension, with a left ventricular ejection fraction of 70%. Angiography prior to discharge showed evidence of ischaemic heart disease with 10 to 20% residual stenosis of the left anterior descending coronary artery and an associated ulcer crater which is the postulated site of occlusion. Serum lipid levels and thyroid function tests performed during this admission were normal. A subsequent dobutamine Sestamibi stress test showed an area of infarction in the anterior myocardial wall but no evidence of inducible ischaemia in the left anterior descending territory.
DISCUSSION
The unusual aspects of this case include the rapid development of ischaemic ECG changes consistent with acute myocardial infarction in the setting of status asthmaticus and that the patient then went on to suffer a pulseless VT arrest, requiring a long period of cardiopulmonary resuscitation. He was subsequently shown to have demonstrable evidence of coronary artery disease but normal systolic function.
Reversible ECG changes described in severe acute asthma include altered P wave morphology (such as P-pulmonale), right axis deviation, right bundle branch block and abnormalities of the ST-segment and T-waves 1,2 . The theoretical mechanisms for these include true myocardial infarction, hypoxaemia and/or acidaemia and the phenomenon of "myocardial stunning", coronary artery vasospasm, sympathetic overstimulation, aggressive β2-agonist therapy and dynamic hyperinflation leading to altered intrathoracic pressures and impaired left ventricular filling. There are isolated case reports in the literature of patients with status asthmaticus developing either acute ECG changes consistent with ischaemia, and/or elevated cardiac enzymes, with left ventricular systolic dysfunction (usually reversible) demonstrated on echocardiography but no significant coronary artery disease. The authors of these reports ascribe the myocardial injuries to coronary artery vasospasm 3, 4 , respiratory failure 5 , β2-agonist therapy 6-8 and stress-induced ("Takotsubo") cardiomyopathy 9, 10 . One other case report describes elevated cardiac enzymes following status asthmaticus but absent ECG changes and normal echocardiography and coronary angiography 11 . In contrast, our patient had normal echocardiographic findings but elevated cardiac enzymes and significant coronary artery disease. It remains highly plausible that myocardial hypoperfusion, hypercatecholaminaemia and β2agonist therapy may have contributed to the pathophysiology of myocardial ischaemia in this instance. We note the findings of a prospective study investigating elevated cardiac enzymes in severe acute asthma which suggested that elevated creatine kinase levels in this setting were unlikely to be cardiac in origin 12 .
A unique aspect of this case arises from the development of a potentially fatal arrhythmia in this patient while still in the resuscitation phase of treatment. In terms of in-hospital mortality from status asthmaticus, cardiac causes are uncommon; deaths are more likely due to pneumothorax, nosocomial pneumonia, sepsis and non-pulmonary organ failure 4, 8 . It is, however, important to note that perhaps more than 50% of asthma-related deaths occur outside the hospital setting 4 . In one other case report of a patient developing VT in the setting of status asthmaticus, the arrhythmia was a polymorphic VT (torsades de pointes) and the patient had received intravenous haloperidol which has been implicated in several other instances of torsades de pointes 13 . A doubleblind study of 41 patients comparing two treatment regimens for acute asthma with respect to cardiac dysrhythmias found that nine patients (20%) developed dysrhythmias, however none of these were ventricular tachycardia or fibrillation 14 . In a recent review of acute asthma in adults, which included discussion regarding asthma mortality, the authors described the theoretical risk of cardiac arrhythmias but noted that the majority of reported arrhythmias were sinus tachycardias and bradycardias 15 .
This patient experienced a good outcome despite the major cardiopulmonary event suffered early on in his presentation; we believe this case highlights the need to consider and anticipate potentially fatal cardiac complications of severe acute asthma, particularly in patients in whom it would be reasonable to suspect pre-existing cardiovascular risk factors.
The patient's verbal consent was obtained prior to submission of this case report.
